Full coverage· Economy· Updated
Israeli Digital Intelligence Firm Cellebrite Cuts Forecasts, Shares Plunge on Wall Street
Israeli digital intelligence firm Cellebrite reported Q2 2026 results below expectations, causing its stock to plunge on Wall Street. The company cut its full-year revenue and ARR forecasts, citing longer sales cycles and slower platform adoption.
2 newsrooms · 1 language · since
Plus
What happened
- 01Cellebrite’s Q2 2026 revenue rose 16% to $131.1 million but missed market expectations.
- 02The company lowered its full-year ARR forecast to $550-560 million and revenue guidance to $555-561 million.
- 03CEO Thomas Hogan was replaced by Shivan Ramji to lead the company’s next growth phase.
- 04Longer sales cycles and slow adoption of platform upgrades caused the financial shortfall.
- 05Analysts maintain a Moderate Buy rating with a $21.80 price target, implying 43% upside.
- 06Cellebrite’s federal security certification and AI tools strengthen its competitive edge.
Concurrently, Cellebrite announced a CEO change, appointing Shivan Ramji to lead the company forward. Despite the setbacks, analysts maintain cautious optimism due to Cellebrite’s strong market position and advanced technology.
The coverage
2 newsrooms on this story
Who covered it
- LeftNone
- CentreNone
- RightNone
- HarediNone
- ArabNone
- Other2
How it broke
See which of the 2 newsrooms broke it, and who waited